Benefits of a mosaic approach for assessing cortical atrophy in individual multiple sclerosis patients

ConclusionThis study provides evidence that MAP yields high potential for a clinically relevant biomarker in MS, outperforming existing methods to compute cortical disease burden in single patients. Of note, MAP outputs brain maps illustrating individual cortical disease burden which can be directly interpreted in daily clinical routine.

Source: Brain and Behavior - November 14, 2023 Category: Neurology Authors: Marlene Tahedl, Tun Wiltgen, Cui Ci Voon, Achim Berthele, Jan S. Kirschke, Bernhard Hemmer, Mark M ühlau, Claus Zimmer, Benedikt Wiestler Tags: ORIGINAL ARTICLE Source Type: research